Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in Depression.
Tavares VDO, da Costa Gonçalves KT, de Morais Barros ML, de Brito AJC, Cavalcanti-Ribeiro P, Palhano-Fontes F, Falchi-Carvalho M, Nunes EA, Sarris J, Perkins D, Fernandes-Osterhold G, de Araujo DB, Galvão-Coelho NL. Tavares VDO, et al. Among authors: falchi carvalho m. J Clin Psychopharmacol. 2024 Dec 23. doi: 10.1097/JCP.0000000000001946. Online ahead of print. J Clin Psychopharmacol. 2024. PMID: 39705718
Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.
da Costa Gonçalves KT, de Tavares VDO, de Morais Barros ML, de Brito AJC, Cavalcanti-Ribeiro P, Palhano-Fontes F, Falchi-Carvalho M, Arcoverde E, Dos Santos RG, Hallak JEC, de Araujo DB, Galvão-Coelho NL. da Costa Gonçalves KT, et al. Among authors: falchi carvalho m. Eur Arch Psychiatry Clin Neurosci. 2024 Oct 28. doi: 10.1007/s00406-024-01925-6. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39467856
Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.
Palhano-Fontes F, Cavalcanti-Ribeiro P, da Costa Gonçalves KT, de Almeida VRN, Barbosa DC, de Araújo Ferreira MA, Bolcont R, De Souza LCAM, Santos NC, Lopes EITC, de Medeiros Lima NB, de Brito AJC, Falchi-Carvalho M, Arcoverde E, Araujo D, Galvão-Coelho NL. Palhano-Fontes F, et al. Among authors: falchi carvalho m. J Affect Disord. 2025 Jan 15;369:155-163. doi: 10.1016/j.jad.2024.09.141. Epub 2024 Sep 26. J Affect Disord. 2025. PMID: 39341294 Clinical Trial.
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.
Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F. Falchi-Carvalho M, et al. Eur Neuropsychopharmacol. 2024 Mar;80:27-35. doi: 10.1016/j.euroneuro.2023.12.006. Epub 2023 Dec 22. Eur Neuropsychopharmacol. 2024. PMID: 38141403 Clinical Trial.